These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 3315451
1. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension. Balazovjech I, Skultétyová D, Mikulecký M, Kratochvíl'ová H. Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451 [Abstract] [Full Text] [Related]
2. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension. Mayer O, Polívková H. Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449 [Abstract] [Full Text] [Related]
4. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus. Dvorák I, Podrouzková B, Kocourková J, Kubesová H, Spác J, Nĕmcová H, Blaha M. Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448 [Abstract] [Full Text] [Related]
7. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension]. Knypl K, Wocial B, Chodakowska J, Brym E, Czerniewska E, Wacławek-Maczkowska J, Kuczyńska K, Berent H, Januszewicz W. Pol Tyg Lek; 1987; 44(12-13):293-6. PubMed ID: 2530502 [Abstract] [Full Text] [Related]
8. [Estulic in the long-term treatment of hypertension]. Rhomberg F. Schweiz Med Wochenschr; 1980 Dec 13; 110(50):1922-4. PubMed ID: 6782668 [Abstract] [Full Text] [Related]
9. [Treatment of arterial hypertension with a single daily dose of guanfacine]. Jardim PC, Rassi S, Lopes M, Simioni PR, Guimarães E, Maranhão MF, Porto CC. Arq Bras Cardiol; 1984 Nov 13; 43(5):365-9. PubMed ID: 6399438 [No Abstract] [Full Text] [Related]
10. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study. Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M. Neth J Med; 1987 Aug 13; 31(1-2):58-65. PubMed ID: 3309693 [No Abstract] [Full Text] [Related]
12. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S. Clin Ther; 1985 Aug 13; 7(2):199-204. PubMed ID: 3886142 [Abstract] [Full Text] [Related]
13. [Effect of guanfacine on arterial blood pressure and serum lipids and lipoproteins]. Sznajderman M, Niegowska J, Sznajderman M. Pol Tyg Lek; 1985 Aug 13; 42(51-52):1637-41. PubMed ID: 3330797 [No Abstract] [Full Text] [Related]
14. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure]. Lifshits NL, Ermolenko VM, Rozhdestvenskaia TM, Tatsievskiĭ VA, Panasiuk VV. Ter Arkh; 1984 Aug 13; 56(7):66-9. PubMed ID: 6385325 [No Abstract] [Full Text] [Related]
15. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg]. Schäfer N, Knaup G. MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):249-52. PubMed ID: 6806612 [No Abstract] [Full Text] [Related]
16. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance]. Schäfer N, Knaup G. Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756 [No Abstract] [Full Text] [Related]
17. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO]. Mayer K, Lupínek Z, Janousek S, Podrouzková B. Cas Lek Cesk; 1984 Oct 26; 123(43):1306-11. PubMed ID: 6391673 [No Abstract] [Full Text] [Related]
18. [Use of estulic in patients with arterial hypertension]. Kukes VG, Spasskiĭ AV, Alkhazov AI, Rudakov AG, Zisel'man SB. Sov Med; 1985 Oct 26; (12):57-61. PubMed ID: 3913006 [No Abstract] [Full Text] [Related]
19. Use of tensiomin (captopril) in the antihypertensive treatment of haemodialysis patients. Kakuk G, Kurta G, Kárpáti I, Mátyus J. Ther Hung; 1990 Oct 26; 38(2):71-6. PubMed ID: 2198678 [Abstract] [Full Text] [Related]
20. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy. Jerie P, Lasance A. Int J Clin Pharmacol Ther Toxicol; 1981 Jun 26; 19(6):279-87. PubMed ID: 7030975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]